EA201300789A1 - Контрастная композиция - Google Patents

Контрастная композиция

Info

Publication number
EA201300789A1
EA201300789A1 EA201300789A EA201300789A EA201300789A1 EA 201300789 A1 EA201300789 A1 EA 201300789A1 EA 201300789 A EA201300789 A EA 201300789A EA 201300789 A EA201300789 A EA 201300789A EA 201300789 A1 EA201300789 A1 EA 201300789A1
Authority
EA
Eurasian Patent Office
Prior art keywords
contrast composition
composition
tetraazacyclodecane
dihydroxy
hydroxymethyl
Prior art date
Application number
EA201300789A
Other languages
English (en)
Inventor
Иоганнес Платцек
Вильхельм Трентманн
Original Assignee
Байер Интеллекчуал Проперти Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43297060&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201300789(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Байер Интеллекчуал Проперти Гмбх filed Critical Байер Интеллекчуал Проперти Гмбх
Publication of EA201300789A1 publication Critical patent/EA201300789A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/04—Calcium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Изобретение касается контрастной композиции, включающей гадобутрол и кальциевый комплекс 10-(2,3-дигидрокси-1-(гидроксиметил)пропил)-1,4,7,10-тетраазациклодекан-1,4,7-ацетилацетоуксусной кислоты с чистотой 99,0% или больше. Изобретение, кроме того, касается композиции, включающей кальциевый комплекс 10-(2,3-дигидрокси-1-(гидроксиметил)пропил)-1,4,7,10-тетраазациклодекан-1,4,7- ацетилацетоуксусной кислоты с чистотой 99,0% или больше и примеси.
EA201300789A 2009-11-04 2010-11-02 Контрастная композиция EA201300789A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102009053171A DE102009053171B4 (de) 2009-11-04 2009-11-04 Verfahren zur Herstellung des Calcium-Komplexes von Dihydroxy-hydroxy-methylpropyl-tetraazacyclododecan-triessigsäure (Calcobutrol)

Publications (1)

Publication Number Publication Date
EA201300789A1 true EA201300789A1 (ru) 2013-12-30

Family

ID=43297060

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201300789A EA201300789A1 (ru) 2009-11-04 2010-11-02 Контрастная композиция
EA201200652A EA020161B9 (ru) 2009-11-04 2010-11-02 Способ получения кальцобутрола

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201200652A EA020161B9 (ru) 2009-11-04 2010-11-02 Способ получения кальцобутрола

Country Status (35)

Country Link
US (1) US9447053B2 (ru)
EP (2) EP2496562B1 (ru)
JP (1) JP5733800B2 (ru)
KR (3) KR101057939B1 (ru)
CN (1) CN102164901B (ru)
AR (1) AR078906A1 (ru)
AU (1) AU2010317166C1 (ru)
BR (1) BR112012010320B1 (ru)
CA (1) CA2777314C (ru)
CL (1) CL2012001172A1 (ru)
CO (1) CO6551758A2 (ru)
CR (1) CR20120235A (ru)
CU (1) CU24105B1 (ru)
CY (1) CY1115051T1 (ru)
DE (1) DE102009053171B4 (ru)
DK (1) DK2496562T3 (ru)
DO (1) DOP2012000126A (ru)
EA (2) EA201300789A1 (ru)
EC (1) ECSP12011866A (ru)
ES (1) ES2462970T3 (ru)
HK (1) HK1161237A1 (ru)
HR (1) HRP20140399T1 (ru)
IL (1) IL219012A0 (ru)
MX (1) MX2012005283A (ru)
MY (1) MY158421A (ru)
NZ (2) NZ612449A (ru)
PE (1) PE20130224A1 (ru)
PL (1) PL2496562T3 (ru)
PT (1) PT2496562E (ru)
RS (1) RS53287B (ru)
SI (1) SI2496562T1 (ru)
TW (1) TWI473794B (ru)
UY (1) UY33002A (ru)
WO (1) WO2011054827A1 (ru)
ZA (1) ZA201202504B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20141325A1 (es) 2011-04-21 2014-10-08 Bayer Ip Gmbh Preparacion de gadobutrol de alta pureza
EP2786768A1 (en) 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
KR101693400B1 (ko) * 2014-09-17 2017-01-05 에스티팜 주식회사 칼코부트롤의 제조방법
KR101646211B1 (ko) * 2014-11-12 2016-08-05 (주)디아이테크 자기공명영상용 조영제의 제조방법
CN105037288B (zh) * 2015-07-23 2017-11-03 上海现代制药海门有限公司 一种布醇的制备方法
CN106620726B (zh) * 2015-10-29 2020-10-02 山东威智百科药业有限公司 一种钆布醇注射液及其制备方法
CN106187930B (zh) * 2016-07-12 2018-10-19 嘉实（湖南）医药科技有限公司 高纯度考布曲钙的制备方法
IL265536B (en) * 2016-09-27 2022-07-01 Bayer Pharma AG A method for the production of a crystalline form of the a modification of calcobuterol
CN110035996B (zh) 2016-11-28 2022-08-09 拜耳医药股份公司 用于磁共振成像的新型高弛豫性钆螯合物
CN109384737A (zh) * 2017-08-04 2019-02-26 天津科伦药物研究有限公司 一种四氮杂环钇络合物及其制备方法和应用
KR101971435B1 (ko) * 2017-08-29 2019-04-24 주식회사 엔지켐생명과학 가도부트롤 중간체 및 이를 이용한 가도부트롤의 제조 방법
KR20190088793A (ko) * 2018-01-19 2019-07-29 주식회사 엔지켐생명과학 칼코부트롤의 제조방법
EP3820853A4 (en) * 2018-07-10 2022-08-17 Biophore India Pharmaceuticals Pvt. Ltd. PROCESS FOR THE PREPARATION OF 2,2',2''-( 10-((2R,3S)-1,3,4-TRIHYDROXY BUTAN-2-YL)-1,4,7,10-TETRAAZACYCLODODECAN-1,4 ,7-TRIYL)-TRIACETIC ACID AND THEIR COMPLEXES
EP3870569A4 (en) * 2018-10-24 2022-08-24 Biophore India Pharmaceuticals Pvt. Ltd. NEW PROCESS FOR THE PREPARATION OF MACROCYCLIC CHELATING TRIACETIC ACID 2,2',2''-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRA AZACYCLODODECANE-1,4,7-TRIYL) AND ITS COMPLEXES WITH PARAMAGNETIC METALLIC IONS
KR20210095168A (ko) * 2018-11-23 2021-07-30 바이엘 악티엔게젤샤프트 조영 매체의 제형 및 그의 제조 방법
KR101979836B1 (ko) * 2019-01-02 2019-05-21 동국생명과학 주식회사 칼코부트롤의 제조방법
CN111039885B (zh) * 2019-12-06 2021-03-05 广州康瑞泰药业有限公司 一种制备高纯度考布曲钙的方法
CN114845990A (zh) 2019-12-20 2022-08-02 伯拉考成像股份公司 钙bopta配合物
KR20210112910A (ko) * 2020-03-06 2021-09-15 주식회사 엔지켐생명과학 가도부트롤 주사제 제조를 위한 부형제인 칼코부트롤의 제조 방법
KR20210114742A (ko) * 2020-03-11 2021-09-24 주식회사 엔지켐생명과학 칼테리돌의 제조방법
CN114573522A (zh) * 2020-11-30 2022-06-03 江苏恒瑞医药股份有限公司 一种考布曲钙的新晶型及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625417C2 (de) 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecan-Derivate
DE3640708C2 (de) * 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4009119A1 (de) 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH0899996A (ja) 1990-03-23 1996-04-16 Yamanouchi Europ Bv Ｉｌ−６抑制組成物
DE4237943C2 (de) * 1992-11-06 1997-10-23 Schering Ag Verfahren zur Herstellung von Metallkomplexen der N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecan- und N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivate
DE4218744C2 (de) 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe
IT1275426B (it) * 1995-05-16 1997-08-07 Bracco Spa Recupero del gadolinio e dei suoi agenti complessanti da soluzioni acquose contenenti i loro complessi
DE19724186C2 (de) 1997-06-02 2002-07-18 Schering Ag Verfahren zur Mono- und 1,7-Bis-N-ß-Hydroxyalkylierung von Cyclen und die entsprechenden N-ß-Hydroxyalkyl-1,4,7,10-tetraazacyclododecan-Li-Salz-Komplexe
IT1292130B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione dell'acido 1,4,7,10-tetraazaciclododecan -1,4,7-triacetico e suoi derivati
IT1293778B1 (it) 1997-07-25 1999-03-10 Bracco Spa 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli
US9016221B2 (en) * 2004-02-17 2015-04-28 University Of Florida Research Foundation, Inc. Surface topographies for non-toxic bioadhesion control
WO2011054480A1 (de) * 2009-11-09 2011-05-12 Bayer Schering Pharma Aktiengesellschaft Gadobutrolherstellung mittels keramischer membran

Also Published As

Publication number Publication date
HRP20140399T1 (hr) 2014-06-06
TW201139387A (en) 2011-11-16
JP2013510117A (ja) 2013-03-21
CA2777314C (en) 2017-09-12
IL219012A0 (en) 2012-06-28
ZA201202504B (en) 2013-06-26
PT2496562E (pt) 2014-05-13
PL2496562T3 (pl) 2014-07-31
UY33002A (es) 2011-06-30
US9447053B2 (en) 2016-09-20
CY1115051T1 (el) 2016-12-14
KR20110058746A (ko) 2011-06-01
KR20110086885A (ko) 2011-08-01
NZ612449A (en) 2015-01-30
AU2010317166C1 (en) 2019-02-28
CU20120072A7 (es) 2012-10-15
BR112012010320B1 (pt) 2019-05-14
EP2599777A1 (en) 2013-06-05
CL2012001172A1 (es) 2012-09-14
ES2462970T3 (es) 2014-05-27
CN102164901A (zh) 2011-08-24
CA2777314A1 (en) 2011-05-12
RS53287B (en) 2014-08-29
KR101251210B1 (ko) 2013-04-08
AU2010317166A1 (en) 2012-05-03
CN102164901B (zh) 2015-03-11
CO6551758A2 (es) 2012-10-31
CR20120235A (es) 2012-08-01
EP2496562B1 (en) 2014-02-12
CA2777314E (en) 2011-05-12
JP5733800B2 (ja) 2015-06-10
MY158421A (en) 2016-10-14
EA201200652A1 (ru) 2012-12-28
AR078906A1 (es) 2011-12-14
TWI473794B (zh) 2015-02-21
US20120309962A1 (en) 2012-12-06
KR20120093388A (ko) 2012-08-22
EP2496562A1 (en) 2012-09-12
HK1161237A1 (en) 2012-08-24
MX2012005283A (es) 2012-10-05
NZ599705A (en) 2014-03-28
BR112012010320A2 (pt) 2016-03-29
SI2496562T1 (sl) 2014-06-30
WO2011054827A1 (en) 2011-05-12
EA020161B1 (ru) 2014-09-30
CU24105B1 (es) 2015-07-30
EA020161B9 (ru) 2018-11-30
PE20130224A1 (es) 2013-03-06
ECSP12011866A (es) 2012-07-31
AU2010317166B2 (en) 2014-11-27
DK2496562T3 (da) 2014-05-12
DE102009053171A1 (de) 2011-05-05
KR101057939B1 (ko) 2011-08-18
DOP2012000126A (es) 2012-08-15
DE102009053171B4 (de) 2011-07-21

Similar Documents

Publication Publication Date Title
EA201300789A1 (ru) Контрастная композиция
ECSP11011514A (es) Compuestos heterocíclicos antivirales
ECSP099818A (es) Procesos para la preparacion de pirazoles
MX347257B (es) Solido de gamma-carbolinas fusionadas con heterociclos substituidos.
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
CY1113131T1 (el) Τα παραγωγα ινδολης ως αγωνιστες υποδοχεων s1p1
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201000950A1 (ru) Азолилметилоксираны, их применение, а также содержащие их средства
MX2014001496A (es) Composicion de liberacion sostenida de prostaciclina.
TR201902788T4 (tr) Nörodejeneratif hastalıkların tedavisinde kullanışlı 1-arilkarbonil-4-oksi-piperidin bileşikleri.
IN2012DN02441A (ru)
MX2009013354A (es) Compuestos de triarilo y composiciones que los contienen.
MX2011010451A (es) Derivados de oxadiazol.
EA201270255A1 (ru) 5-фтор-2-оксопиримидин-1(2h)-карбоксилатные производные
EA201201623A1 (ru) Лечение диабета 2 типа
TN2010000219A1 (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
BRPI0720050A2 (pt) 6-oxo-1,6-diidropirimidin-2-ilas no tratamento de doenças proliferativas
EA201270253A1 (ru) Производные n1-ацил-5-фторпиримидинона
EA201071367A1 (ru) Соли соединений ингибиторов вич
MY149433A (en) Nutritional compositions containing punicalagins
EA201290446A1 (ru) Полимерные материалы
MX2012007834A (es) Derivados de acido carboxilico que comprenden un anillo de oxazolopirimidina 2,5-sustituido.
MX2010002007A (es) Sulfonas ciclicas sustituidas por amino-bencilo utiles como inhibidores de bace.
SI2060568T1 (sl) Polimorfi enantiomerno äśistega erdosteina